• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail

CMC Information Request, April 19, 2012 - ALLOCORD

 

(System Info - 210850 TULL LORI 08/23/2012 14:07:23 TULL)
From:        Tull, Lori
Sent:          Thursday, April 19, 2012 1:56 PM
To:             'Donna Regan'
Subject:     CMC information request
 
Hi Donna,
 
Dr. Joydeep Ghosh has the following requests for information regarding your April 6 emailed response:
 
1. Attachment B: Under Column heading "Sample Type" - what is the difference between "--------------------(b)(4)-----------------" vs "---------------------(b)(4)----------------"?
2. Attachment D: There are two types of ---(b)(4)--- media - "----------------------------------------------(b)(4)---------------------------------" - please clarify i) which one was used for the assay described under Table 10 and ii) which one will be used for testing the sterility of the future licensed product?

 
Best Regards,
Lori
 
 
Lori A. Tull, RAC
Regulatory Project Manager
Office of Cellular, Tissue, and Gene Therapies
Center for Biologics Evaluation and Research
(301) 827-5359
 
THIS MESSAGE IS INTENDED ONLY FOR THE USE OF THE PARTY TO WHOM IT IS ADDRESSED AND MAY CONTAIN INFORMATION THAT IS PRIVILEGED, CONFIDENTIAL, AND PROTECTED FROM DISCLOSURE UNDER LAW. If you are not the addressee, or a person authorized to deliver the document to the addressee, you are hereby notified that any review, disclosure, dissemination, copying, or other action based on the content of this communication is not authorized. If you have received this document in error, please immediately notify the sender immediately by e-mail or phone.